Form 8-K - Current report:
SEC Accession No. 0001104659-25-075956
Filing Date
2025-08-11
Accepted
2025-08-11 08:35:49
Documents
19
Period of Report
2025-08-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2523010d1_8k.htm   iXBRL 8-K 31557
2 EXHIBIT 4.1 tm2523010d1_ex4-1.htm EX-4.1 101050
3 EXHIBIT 5.1 tm2523010d1_ex5-1.htm EX-5.1 9583
4 EXHIBIT 10.1 tm2523010d1_ex10-1.htm EX-10.1 202453
5 EXHIBIT 10.2 tm2523010d1_ex10-2.htm EX-10.2 85787
6 EXHIBIT 99.1 tm2523010d1_ex99-1.htm EX-99.1 9337
10 GRAPHIC tm2523010d1_ex5-1img001.jpg GRAPHIC 3239
11 GRAPHIC tm2523010d1_ex99-1img001.jpg GRAPHIC 28476
  Complete submission text file 0001104659-25-075956.txt   757303

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA ocgn-20250808.xsd EX-101.SCH 3008
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE ocgn-20250808_lab.xml EX-101.LAB 34239
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ocgn-20250808_pre.xml EX-101.PRE 22354
21 EXTRACTED XBRL INSTANCE DOCUMENT tm2523010d1_8k_htm.xml XML 3554
Mailing Address 11 GREAT VALLEY PARKWAY MALVERN PA 19355
Business Address 11 GREAT VALLEY PARKWAY MALVERN PA 19355 484-328-4701
Ocugen, Inc. (Filer) CIK: 0001372299 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36751 | Film No.: 251200338
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)